2024-04-26  4:42:42 PM Chg. +1.650 Volume Bid10:00:01 PM Ask10:00:01 PM Market Capitalization Dividend Y. P/E Ratio
225.050EUR +0.74% 56
Turnover: 12,613
224.600Bid Size: 20 225.650Ask Size: 20 66.62 bill.EUR - -

Business description

Cencora, formerly known as AmerisourceBergen, is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, Cencora delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.
 

Management board & Supervisory board

CEO
Steven H. Collis
Management board
James F. Cleary, Jr., Elizabeth S. Campbell, Gina K. Clark, Kourosh Q. Pirouz, Lazarus Krikorian, Leslie E. Donato, Robert P. Mauch, Silvana Battaglia, Jennifer Dubas
Supervisory board
Steven H. Collis, D. Mark Durcan, Dennis M. Nally, Henry W. McGee, Kathleen W. Hyle, Lon R. Greenberg, Ornella Barra, Richard W. Gochnauer, Redonda Miller, Lorence H. Kim, M.D.
 

Company data

Name: Cencora Inc
Address: 1 West First Avenue,Conshohocken, PA 19428-1800, USA
Phone: +1-610-727-7000
Fax: +1-800-640-5221
E-mail: InvestorRelations@cencora.com
Internet: https://www.cencora.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 09-30
Free Float: 55.10%
IPO date: 1995-04-04

Investor relations

Name: Bennett Murphy
IR phone: +1-610-727-3693
IR Fax: -
IR e-mail: bennett.murphy@cencora.com

Company calendar

CW 18 | 2024-05-01 Interim Report 2nd Quarter/6 Months
 

Main Shareholders

Others
 
59.68%
Vanguard Group Inc
 
10.37%
Blackrock Inc.
 
8.43%
Price (T.Rowe) Associates Inc
 
5.45%
State Street Corporation
 
3.83%
JP Morgan Chase & Company
 
3.46%
Boston Partners
 
2.46%
Geode Capital Management, LLC
 
1.73%
FMR, LLC
 
1.71%
Others
 
2.88%